X

Vous n'êtes pas connecté

Maroc Maroc - PHARMABIZ.COM - A la Une - 23/Aug 00:00

US FDA clears ImmPACT Bio's IND application for CD19/CD20 bispecific CAR─T cell therapy in multiple sclerosis

ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical─stage biopharmaceutical company, announced the United States Food and Drug Administration (FDA) has cleared an investigational new drug

Articles similaires

Sorry! Image not available at this time

FDA Approves Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) Twice-A-Year Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis

drugs.com - 05:09

South San Francisco, CA -- September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United...

Sorry! Image not available at this time

KalVista announces FDA acceptance of NDA for sebetralstat for oral on-demand treatment of HAE

haei.org - 03/Sep 17:29

KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...

Sorry! Image not available at this time

KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

drugs.com - 03/Sep 20:09

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....

Sorry! Image not available at this time

Worldwide Clinical Trials - USA: Senior Clinical Research Associate* - CAR-T and Cell Therapy

pharmiweb.com - 12/Sep 00:00

Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...

Sorry! Image not available at this time

Worldwide Clinical Trials - USA: Senior Clinical Research Associate* - CAR-T and Cell Therapy

pharmiweb.com - 12/Sep 00:00

Competitive: Worldwide Clinical Trials - USA: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...

CAR T-Cell Therapy: FDA Warning on Secondary Cancer Risks

medindia.net - 00:35

Learn why the FDA has mandated boxed warnings for CAR T-cell therapies, highlighting the risks of secondary malignancies.

Sorry! Image not available at this time

Indies Pharma looking to double sales after securing FDA drug approval

jamaica-gleaner.com - 11/Sep 05:05

Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...

CAR T-Cell Therapy: FDA Warning on Secondary Cancer Risks

medindia.net - 16/Sep 11:03

Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c

CAR T-Cell Therapy: FDA Warning on Secondary Cancer Risks

medindia.net - 16/Sep 11:03

Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c

Sorry! Image not available at this time

Stealth BioTherapeutics to receive FARA grant to develop investigational mitochondrial therapeutic SBT─589 for Friedreich's ataxia

pharmabiz.com - 13/Sep 16:48

Stealth BioTherapeutics Inc., a clinical─stage biotechnology company focused on the discovery, development and commercialization of novel therapies...

Les derniers communiqués

  • Aucun élément